- ►diabetesjournals.org RHJ Bandsma, CH Wiegman, AW Herling, HJ … - Diabetes, 2001 - Am Diabetes Assoc Glucose-6-phosphatase (G6Pase) is a key enzyme in hepatic glucose metabolism.
Altered G6Pase activity in glycogen storage disease and diabetic states is
associated with disturbances in lipid metabolism. We studied the effects of ... Cited by 35 - Related articles - BL Direct - All 9 versions
AP Germany, G Frankfurt - dissertations.ub.rug.nl Glucose-6-phosphatase (G6Pase) is a key enzyme in hepatic glucose metabolism.
Altered G6Pase activity in Glycogen Storage Disease and diabetic states is
associated with disturbances in lipid metabolism. We studied the effects of ... Related articles - View as HTML - All 3 versions
- ►rug.nl [PDF] CH Wiegman, RHJ Bandsma, M Ouwens, FH van … - Diabetes, 2003 - Am Diabetes Assoc Type 2 diabetes in humans is associated with increased de novo lipogenesis
(DNL), increased fatty acid (FA) fluxes, decreased FA oxidation, and hepatic
steatosis. In this condition, VLDL production is increased and resistant to ... Cited by 41 - Related articles - BL Direct - All 7 versions
RHJ Bandsma, JP Rake, G Visser, RA Neese, … - JOURNAL OF PEDIATRICS, 2002 - dissertations.ub.rug.nl Glycogen storage disease type 1a (von Gierke disease) is an inborn error of
metabolism caused by deficiency of G6Pase, the enzyme catalyzing the conversion
of G6P to glucose. The disease is characterized by hypoglycemia and hepatic ... Cited by 17 - Related articles - View as HTML - BL Direct - All 10 versions
- ►physiology.org A Grefhorst, J Hoekstra, TGJ Derks, DM … - American Journal of Physiology- Gastrointestinal and …, 2005 - Am Physiological Soc Accumulation of triglycerides (TG) in the liver is generally associated with
hepatic insulin resistance. We questioned whether acute hepatic steatosis
induced by pharmacological blockade of -oxidation affects hepatic insulin ... Cited by 17 - Related articles - BL Direct - All 10 versions
AW Herling, HJ Burger, G Schubert, H … - European journal of pharmacology, 1999 - Elsevier S 4048 (1-[2-(4-Chloro-phenyl)-cyclopropylmethoxy]-3,4-dihydroxy-5-(3-imidazo[4,
5-b]pyridin-1-yl-3-phenyl-acryloyloxy)-cyclohexanecarboxylic acid), a derivative
of chlorogenic acid, specifically inhibits the glucose-6-phosphate ... Cited by 36 - Related articles - All 5 versions
WJ Arion, WK Canfield, FC Ramos, ML Su, HJ … - Archives of Biochemistry and Biophysics, 1998 - Elsevier S 3483, a synthetic derivative of chlorogenic acid (CHL), was found to be a
reversible, linear competitive inhibitor of the glucose-6-phosphatase
(Glc-6-Pase) system in rat renal microsomes and rat and human liver ... Cited by 38 - Related articles - BL Direct - All 6 versions
TH van Dijk, FH van der Sluijs, CH Wiegman, … - Journal of Biological Chemistry, 2001 - ASBMB Effects of acute inhibition of glucose-6-phosphatase activity by the chlorogenic
acid derivative S4048 on hepatic carbohydrate fluxes were examined in isolated
rat hepatocytes and in vivo in rats. Fluxes were calculated using tracer ... Cited by 9 - Related articles - All 2 versions
N Westergaard, P Madsen, JM Lundbeck, P … - Diabetes Obesity and Metabolism, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 9 - Related articles - BL Direct - All 5 versions
N Bashan, R Potashnik, A Peist, N Peleg, A … - European Journal of Pediatrics, 1993 - Springer Abstract. Patients with glycogen storage disease (GSD) lb suffer from recurrent
bacterial infections related to neutropenia and impairment of neutrophil
functions. One of these functions is the oxidative burst activity which is ... Cited by 10 - Related articles - BL Direct - All 3 versions
